Incidence, delays, and outcomes of STEMI during COVID-19 outbreak: Analysis from the France PCI registry.

ABSTRACT:

Objectives

The aim of this study was to assess the impact of the coronavirus disease 2019 (COVID-19) outbreak on incidence, delays, and outcomes of ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI) in France.

Methods

We analyzed all patients undergoing PPCI <24 hours STEMI included in the prospective France PCI registry. The 2 groups were compared on mean monthly number of patients, delays in the pathway care, and in-hospital major adverse cardiac events (MACE: death, stent thrombosis, myocardial infarction, unplanned coronary revascularization, stroke, and major bleeding).

Results

From January 15, 2019 to April 14, 2020, 2064 STEMI patients undergoing PPCI were included: 1942 in the prelockdown group and

SUBMITTER: Range G 

PROVIDER: S-EPMC7753646 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature